Canagliflozin Provided Substantial and Sustained Glycemic Improvements as Monotherapy and in Add-On Combinations in Adults with Type 2 Diabetes in Five Phase 3 Studies Canagliflozin Provides Greater ...
In the current era of multiple therapies for pulmonary arterial hypertension (PAH), the use of combination therapy is becoming common. The REVEAL registry demonstrated that nearly 50% of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results